Cerus Corp. (CERS)

5.47
NASDAQ : Health Technology
Prev Close 5.49
Day Low/High 5.43 / 5.56
52 Wk Low/High 4.71 / 8.05
Avg Volume 828.00K
Exchange NASDAQ
Shares Outstanding 137.84M
Market Cap 756.72M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cerus Corporation Announces Record First Quarter 2019 Results

Cerus Corporation Announces Record First Quarter 2019 Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2019.

Cerus Corporation To Release First Quarter 2019 Results On May 7, 2019

Cerus Corporation To Release First Quarter 2019 Results On May 7, 2019

Cerus Corporation (Nasdaq:CERS) announced today that its first quarter 2019 results will be released on Tuesday, May 7, 2019, after the close of the stock market.

Cerus Becomes Oversold (CERS)

Cerus Becomes Oversold (CERS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus Breaks Below 200-Day Moving Average - Notable For CERS

Cerus Breaks Below 200-Day Moving Average - Notable For CERS

In trading on Friday, shares of Cerus Corp. crossed below their 200 day moving average of $6.39, changing hands as low as $6.35 per share.

Cerus Corporation Strengthens Balance Sheet With An Expandable Debt Facility Of Up To $90 Million

Cerus Corporation Strengthens Balance Sheet With An Expandable Debt Facility Of Up To $90 Million

Cerus Corporation (Nasdaq: CERS) today announced the closing of a new debt facility with MidCap Financial (MidCap) which is expandable up to $90 million.

Cerus Corporation Announces Appointment Of Jami Nachtsheim To Board Of Directors

Cerus Corporation Announces Appointment Of Jami Nachtsheim To Board Of Directors

Cerus Corporation (Nasdaq: CERS) today announced the appointment of Jami Nachtsheim to its Board of Directors.

Cerus Corporation Announces Record Fourth Quarter And Full Year 2018 Results

Cerus Corporation Announces Record Fourth Quarter And Full Year 2018 Results

Cerus Corporation (Nasdaq: CERS) today announced complete financial results for the fourth quarter and year ended December 31, 2018.

Cerus To Participate In Upcoming Investor Conferences

Cerus To Participate In Upcoming Investor Conferences

Cerus Corporation (Nasdaq:CERS) announced today that the Company will participate in two upcoming investor conferences.

Bullish Two Hundred Day Moving Average Cross - CERS

Bullish Two Hundred Day Moving Average Cross - CERS

In trading on Wednesday, shares of Cerus Corp. crossed above their 200 day moving average of $6.40, changing hands as high as $6.42 per share.

Cerus To Release Fourth Quarter And Full Year 2018 Results On February 26, 2019

Cerus To Release Fourth Quarter And Full Year 2018 Results On February 26, 2019

Cerus Corporation (Nasdaq:CERS) announced today that its fourth quarter and full-year 2018 results will be released on Tuesday, February 26, 2019, after the close of the stock market.

Cerus Announces Preliminary Fourth Quarter And Full Year 2018 Product Revenue

Cerus Announces Preliminary Fourth Quarter And Full Year 2018 Product Revenue

Cerus Corporation (Nasdaq:CERS) today announced unaudited preliminary product revenue for the fourth quarter and full year 2018 and provided 2019 product revenue guidance.

William Moore Appointed As Cerus Corporation's Senior Vice President Of Manufacturing Operations And Supply Chain

William Moore Appointed As Cerus Corporation's Senior Vice President Of Manufacturing Operations And Supply Chain

Cerus Corporation (Nasdaq:CERS) announced today the appointment of William Moore to the newly created position of Senior Vice President of Manufacturing Operations and Supply Chain for Cerus, effective January 1, 2019.

First Week Of CERS August 16th Options Trading

First Week Of CERS August 16th Options Trading

Investors in Cerus Corp. saw new options begin trading this week, for the August 16th expiration.

Cerus Announces First Patient Enrolled In The Phase 3 ReCePI Study

Cerus Announces First Patient Enrolled In The Phase 3 ReCePI Study

Cerus Corporation (Nasdaq:CERS) today announced the initiation and first patient enrollment in ReCePI, a randomized, double-blinded, controlled, parallel group, non-inferiority, Phase 3 study to evaluate the efficacy and safety of the INTERCEPT Blood...

Cerus Completes CE Mark Submission For INTERCEPT Red Blood Cells

Cerus Completes CE Mark Submission For INTERCEPT Red Blood Cells

Cerus Corporation (Nasdaq:CERS) today announced that it has filed for CE Mark registration for the Company's INTERCEPT red blood cell (RBC) system.

American Red Cross Receives Biologics License Application Approval For INTERCEPT Platelets

American Red Cross Receives Biologics License Application Approval For INTERCEPT Platelets

Cerus Corporation (Nasdaq:CERS) announced today that the American Red Cross has received approval by the U.

Cerus Supports FDA's Continuing Efforts To Enhance The Safety Of The U.S. Platelet Supply

Cerus Supports FDA's Continuing Efforts To Enhance The Safety Of The U.S. Platelet Supply

Cerus Corporation (Nasdaq:CERS) announced today the issuance of a new U.S.

Relative Strength Alert For Cerus

Relative Strength Alert For Cerus

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus To Present At The 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Cerus To Present At The 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Cerus Corporation (Nasdaq:CERS) announced today that William 'Obi' Greenman, Cerus' president and chief executive officer, and Vivek Jayaraman, Cerus' chief commercial officer, are scheduled to present a corporate update at the 2018 Canaccord Genuity...

CERS Makes Notable Cross Below Critical Moving Average

CERS Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of Cerus Corp. crossed below their 200 day moving average of $6.19, changing hands as low as $5.83 per share.

Cerus To Present At The 2018 Stephens NY Investment Conference

Cerus To Present At The 2018 Stephens NY Investment Conference

Cerus Corporation (Nasdaq:CERS) announced today that William 'Obi' Greenman, Cerus' president and chief executive officer, and Kevin Green, Cerus' vice president, finance and chief financial officer, are scheduled to present a corporate update at the 2018...

Cerus Corporation Reports Third Quarter 2018 Results

Cerus Corporation Reports Third Quarter 2018 Results

Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2018.

Cerus Receives FDA Breakthrough Device Designation For Pathogen-Reduced Cryoprecipitate

Cerus Receives FDA Breakthrough Device Designation For Pathogen-Reduced Cryoprecipitate

Cerus Corporation (Nasdaq:CERS) announced today that the U.S.

First Week Of CERS December 21st Options Trading

First Week Of CERS December 21st Options Trading

Investors in Cerus Corp. saw new options begin trading this week, for the December 21st expiration.

Cerus To Release Third Quarter 2018 Results On November 1, 2018

Cerus To Release Third Quarter 2018 Results On November 1, 2018

Cerus Corporation (Nasdaq:CERS) announced today that its third quarter results will be released on Thursday, November 1, 2018, after the close of the stock market.

Cerus To Provide Update To Development Programs And Outline Growth Strategy At 2018 Institutional Investor Meeting

Cerus To Provide Update To Development Programs And Outline Growth Strategy At 2018 Institutional Investor Meeting

Cerus Corporation (Nasdaq: CERS) is presenting its strategic roadmap and outlining its multi-year growth strategy at the 2018 Cerus Institutional Investor Meeting today in Boston.

Cerus Announces Schedule Of Presentations At The 2018 AABB Annual Meeting

Cerus Announces Schedule Of Presentations At The 2018 AABB Annual Meeting

Cerus Corporation (Nasdaq: CERS) announced today its schedule of key events and presentations at the 2018 AABB Annual Meeting which is taking place in Boston on October 13 through October 16.

Dr. Laurence Corash Recognized With The Prestigious Dale A. Smith Memorial Award

Dr. Laurence Corash Recognized With The Prestigious Dale A. Smith Memorial Award

Cerus Corporation (Nasdaq: CERS) today announced Dr. Laurence Corash, the Company's co-founder and chief scientific officer has been awarded the prestigious Dale A.

TheStreet Quant Rating: D- (Sell)